文献速递造血干细胞移植与细胞治疗血栓与止血

再生胰岛衍生蛋白3-α是胃肠道慢性移植物抗宿主病的预后生物标志物

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.
PubMed 文献 · Blood Adv · 2022-01-01

在289例慢性移植物抗宿主病(cGVHD)患者的两个独立队列中分析Reg3α、CXCL9和ST2三种蛋白标志物,发现胃肠道cGVHD患者血浆Reg3α浓度显著升高,高Reg3α(≥72 ng/mL)患者非复发死亡率更高(23% vs 11%;P = .015),多变量Cox回归中高Reg3α患者无复发生存死亡风险为1.9倍。

要点

  • 胃肠道cGVHD患者血浆Reg3α浓度显著升高(P = .0012),CXCL9和ST2未见显著升高。
  • 高Reg3α(≥72 ng/mL)患者非复发死亡率高于低Reg3α患者(23% vs 11%;P = .015)。
  • 多变量Cox回归中高Reg3α患者无复发生存死亡风险为1.9倍。

核心结论

  • Reg3α可作为胃肠道cGVHD的预后标志物。
  • 这些数据提示需开展前瞻性生物标志物验证研究。

研究设计与样本

  • 在两个独立的cGVHD患者队列(共289例)中分析Reg3α、CXCL9和ST2三种蛋白标志物。

主要发现

  • 胃肠道cGVHD患者血浆Reg3α浓度较无胃肠道cGVHD者显著升高(P = .0012),而CXCL9和ST2未见显著升高(P = .01)。
  • 高Reg3α(≥72 ng/mL)患者非复发死亡率高于低Reg3α患者(23% vs 11%;P = .015)。
  • Reg3α在急性样下消化道cGVHD与经典纤维化样食管表现之间无差异,上消化道与下消化道亚型之间也无差异。
  • 极高Reg3α(≥180 ng/mL)患者胃肠道评分更高,但下消化道评分未更高。
  • 多变量Cox回归模型中,高Reg3α患者无复发生存死亡风险为1.9倍。

局限性

  • 原文指出这些数据需开展前瞻性生物标志物验证研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prognostic biomarkers used to identify likelihood of disease progression have not been identified for chronic graft-versus-host disease (cGVHD), the leading cause of late nonrelapse mortality (NRM) in survivors of allogeneic hematopoietic cell transplantation. Gastrointestinal cGVHD (GI-cGVHD) has been particularly challenging to classify. Here, we analyzed 3 proteomics markers (Regenerating islet-derived protein 3-α [Reg3α], C-X-C motif ligand 9 [CXCL9], and Stimulation-2 [ST2]) in 2 independent cohorts of patients with cGVHD totaling 289 patients. Plasma concentrations of Reg3α were significantly increased in patients with GI-cGVHD (P = .0012) compared with those without (P = .01), but plasma concentrations of CXCL9 and ST2 were not. Patients with high Reg3α (≥72 ng/mL) vs low Reg3α had higher NRM (23% vs 11%; P = .015). Because Reg3α has been identified as a lower GI tract marker in acute GVHD, we correlated Reg3α with lower acute-like GI-cGVHD vs classical fibrotic-like esophageal manifestations and found that Reg3α did not differ between the subtypes. No difference was observed between upper GI tract and lower GI tract subtypes. Patients with extremely high Reg3α (≥180 ng/mL) had higher GI scores but not higher scores for the lower GI tract. In a multivariable Cox regression model, patients with high Reg3α were 1.9 times more likely to die without relapse. Our findings demonstrate the utility of Reg3α as a prognostic marker for GI-cGVHD. These data warrant prospective biomarker validation studies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. DePriest BP, Li H, Bidgoli A, et al. Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease. Blood Adv. 2022. PMID: 35030629. doi:10.1182/bloodadvances.2021005420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。